Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors
- Cite this article as:
- Kaumann, A.J. Naunyn-Schmiedeberg's Arch. Pharmacol. (1983) 323: 149. doi:10.1007/BF00634263
- 26 Downloads
The α2-adrenoceptor blockers rauwolscine and yohimbine antagonized competitively 5 HT-induced contractions. The estimated equilibrium dissociation constantsKB (−log mol/l) were 7.1 for rauwolscine and 7.3 for yohimbine. The affinity of yohimbine for the receptors mediating the response to 5HT appears to be 10 times higher than for postsynaptic α1-adrenoceptor but 10 times lower than for postsynaptic vascular α2-adrenoceptor.
(−)-Noradrenaline and the α2-adrenoceptor agonist B-HT 920 caused maximum contractions amounting to only 20% and 2%, respectively, of the maximum 5 HT effects. Neither 60 μmol/l B-HT 920 nor 1 μmol/l prazosin antagonized the 5 HT effect.
Ketanserin was a competitive antagonist (KB=9.2 (−log mol/l)) of the effects of 5 HT. Combinations of rauwolscine or yohimbine with ketanserin antagonized the 5 HT effects as expected from competition of the 4 drugs for a single class of receptor.
The evidence is consistent with an interaction of 5 HT, ketanserin, rauwolscine and yohimbine with 5 HT2 receptors. α-Adrenoceptors only play a minor role in large coronary arteries and appear not to be involved in the 5 HT-induced contractions. A possible clinical involvement of 5 HT in coronary artery spasm is discussed.